Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOMILNACIPRAN: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

80.2%
Female
19.8%
Male

Age Information

The average age of patients reporting adverse events with LEVOMILNACIPRAN is 46.4 years.

Geographic Distribution

The majority of adverse event reports for LEVOMILNACIPRAN originate from US.

Report Summary & Outcomes

1,378
Total Reports
1,378
As Primary/Secondary Suspect
382
Deaths Reported
378
Hospitalizations
276
Life-Threatening
254
Disabilities

Reporting Timeline

First adverse event report: 200805. Most recent report: 20250911. View full timeline →

More About LEVOMILNACIPRAN

LEVOMILNACIPRAN Full Profile Reports by Year Drug Interactions